Treatment of Metastatic Breast Cancer with AZQ: A Phase II Trial
作者:
MartinoSilvana,
RatanatharathomVorachai,
SamalBohumil A.,
SinghakowintaAmnuay,
HaasCharles,
期刊:
Cancer Investigation
(Taylor Available online 1988)
卷期:
Volume 6,
issue 3
页码: 289-291
ISSN:0735-7907
年代: 1988
DOI:10.3109/07357908809080651
出版商: Taylor&Francis
数据来源: Taylor
摘要:
AbstractSeventeen patients with metastatic breast cancer who had failed prior chemotherapy were treated with intravenous AZQ at a dose of 15-20 mg/m2weekly for four consecutive weeks followed by a two-week rest period. No responses were observed. Myelosuppression was the dose-limiting toxicity. One patient experienced massive liver infarction possibly related to AZQ. Our data suggest that this agent at the schedule and dosage used is of no benefit in pretreated breast cancer patients.
点击下载:
PDF (200KB)
返 回